Dr. Reddy's Laboratories Limited — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · India
Last price 14.11 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 11.81B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Details
| Name | Dr. Reddy's Laboratories Limited |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 27527 |
| Founded | 1984 |
| Ceo | Erez Israeli |
| Country | India |
| Exchange | NYSE |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| Isin | US2561352038 |
| Cusip | 256135203 |
| Cik | 0001135951 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Motupalli Venkata Ramana M.B.A. | Chief Executive Officer of Global Generics and Member of Management Council |
| Deepak Sapra M.B.A. | Chief Executive Officer ? API and Services and Member of Management Council |
| Erez Israeli M.B.A. | Chief Executive Officer and Member of the Management Council |
| Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD and Member of Management Council |
| Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board and Member of the Management Council |
| Mannam Venkatanarasimham | Chief Financial Officer and Member of the Management Council |
| Krishna K. Venkatesh B.Pharma M.S. | Global Head of IPDO, Integrated Product Development and Member of the Management Council |
| Sanjay Sharma B.Tech. | Executive Vice President, Chief Operating Officer and Member of Management Council |
| Patrick Aghanian B.A., M.B.A. | Head of Consumer Health Organization and Member of Management Council |
| Bhethanabottla S. Phanimitra | Chief Digital and Information Officer and Member of the Management Council |
Contact
| Address | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, 500034, India |
| Phone | 91 40 4900 2900 |
| Website | https://www.drreddys.com |